tazobactam has been researched along with Pyelonephritis in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 4 (36.36) | 2.80 |
| Authors | Studies |
|---|---|
| Gillani, SW; Hussain, MW; Mahmood, RK; Rathore, HA; Saeed, MW; Vippadapu, P | 1 |
| Ashouri, N; Bensaci, M; Bradley, JS; Bruno, CJ; De Anda, C; Huntington, JA; Johnson, MG; Lonchar, J; Popejoy, MW; Rhee, EG; Roilides, E; Su, FH | 1 |
| Belley, A; Kaye, KS; Velicitat, P | 1 |
| Hsu, CK; Lai, CC; Tsai, WW | 1 |
| Huntington, JA; Long, J; Popejoy, MW | 1 |
| Aoyama, N; Arakawa, S; Fujimoto, G; Kawahara, K; Kawahara, M; Rhee, EG; Sato, A; Yasuda, M; Yokokawa, R; Yoshinari, T | 1 |
| Harris, PNA | 1 |
| Darouiche, RO; Steenbergen, J; Umeh, O; Wagenlehner, FM; Yuan, G | 1 |
| Geerlings, SE; Holleman, F; Schneeberger, C | 1 |
| Ahmed, S; Gouda, HE; Najjar, M; Rodriguez, P | 1 |
| Naber, KG; Salmen, HC; Savov, O | 1 |
2 review(s) available for tazobactam and Pyelonephritis
| Article | Year |
|---|---|
A Meta-Analysis on Clinical Outcomes of Ceftolozane versus Piperacillin in Combination with Tazobactam in Patients with Complicated Urinary Tract Infections.
Topics: Anti-Bacterial Agents; Cephalosporins; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyelonephritis; Tazobactam; Urinary Tract Infections | 2022 |
Febrile urinary tract infections: pyelonephritis and urosepsis.
Topics: Anti-Infective Agents, Urinary; Cephalosporins; Diabetes Complications; Fever; Humans; Immunocompromised Host; Levofloxacin; Penicillanic Acid; Pyelonephritis; Randomized Controlled Trials as Topic; Risk Factors; Sepsis; Tazobactam; Treatment Outcome; Urinary Tract Infections | 2016 |
5 trial(s) available for tazobactam and Pyelonephritis
| Article | Year |
|---|---|
Safety and Efficacy of Ceftolozane/Tazobactam Versus Meropenem in Neonates and Children With Complicated Urinary Tract Infection, Including Pyelonephritis: A Phase 2, Randomized Clinical Trial.
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Child; Escherichia coli; Humans; Infant, Newborn; Meropenem; Penicillanic Acid; Pyelonephritis; Tazobactam; Urinary Tract Infections | 2023 |
Analysis of patients with diabetes and complicated intra-abdominal infection or complicated urinary tract infection in phase 3 trials of ceftolozane/tazobactam.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Diabetes Complications; Diabetes Mellitus; Female; Humans; Intraabdominal Infections; Levofloxacin; Male; Metronidazole; Middle Aged; Penicillanic Acid; Pyelonephritis; Tazobactam; Urinary Tract Infections | 2017 |
The efficacy and safety of tazobactam/ceftolozane in Japanese patients with uncomplicated pyelonephritis and complicated urinary tract infection.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Japan; Male; Middle Aged; Pyelonephritis; Tazobactam; Treatment Outcome; Urinary Tract Infections | 2019 |
Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI).
Topics: Adult; Aged; Anti-Infective Agents, Urinary; Cephalosporins; Double-Blind Method; Drug Administration Schedule; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Levofloxacin; Male; Middle Aged; Penicillanic Acid; Pyelonephritis; Tazobactam; Treatment Outcome; Urinary Tract Infections; Young Adult | 2015 |
Piperacillin 2 g/tazobactam 0.5 g is as effective as imipenem 0.5 g/cilastatin 0.5 g for the treatment of acute uncomplicated pyelonephritis and complicated urinary tract infections.
Topics: Adolescent; Adult; Aged; Cilastatin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Pyelonephritis; Sample Size; Tazobactam; Thienamycins; Urinary Tract Infections | 2002 |
4 other study(ies) available for tazobactam and Pyelonephritis
| Article | Year |
|---|---|
Cefepime/Enmetazobactam vs Piperacillin/Tazobactam and Complicated Urinary Tract Infection or Acute Pyelonephritis-Reply.
Topics: Cefepime; Humans; Piperacillin; Pyelonephritis; Tazobactam; Urinary Tract Infections | 2023 |
Cefepime/Enmetazobactam vs Piperacillin/Tazobactam and Complicated Urinary Tract Infection or Acute Pyelonephritis.
Topics: Anti-Bacterial Agents; Cefepime; Drug Therapy, Combination; Humans; Piperacillin; Pyelonephritis; Tazobactam; Urinary Tract Infections | 2023 |
By ZEUS! Can We Use Intravenous Fosfomycin for Complicated Urinary Tract Infections?
Topics: Fosfomycin; Humans; Piperacillin; Pyelonephritis; Tazobactam; Urinary Tract Infections | 2019 |
Successful medical management of emphysematous pyelonephritis.
Topics: Adult; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Emphysema; Female; Follow-Up Studies; Humans; Insulin; Magnetic Resonance Imaging; Penicillanic Acid; Piperacillin; Pyelonephritis; Tazobactam; Tomography, X-Ray Computed; Treatment Outcome | 2002 |